Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3324)
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
220,000
Price
$4.20
Total Value
$924.00K
Shares Held After
6,429,863
% of Holdings
3.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,790
Price
$76.73
Total Value
$597.76K
Shares Held After
708,719
% of Holdings
1.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,659
Price
$75.94
Total Value
$733.54K
Shares Held After
716,509
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,551
Price
$74.88
Total Value
$191.02K
Shares Held After
726,168
% of Holdings
0.4%
ProMIS Neurosciences Inc. (PMN)
ABG Management Ltd. — 10% Owner
Shares
700,741
Price
$12.13
Total Value
$8.50M
Shares Held After
943,090
% of Holdings
74.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.87
Total Value
$817.33K
Shares Held After
1,235
% of Holdings
94.2%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,170
Price
$15.25
Total Value
$17.84K
Shares Held After
156,052
% of Holdings
0.7%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
3,000
Price
$14.82
Total Value
$44.47K
Shares Held After
157,222
% of Holdings
1.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
323
Price
$1.82
Total Value
$588.51
Shares Held After
514,551
% of Holdings
0.1%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,559
Price
$4.10
Total Value
$22.79K
Shares Held After
550,000
% of Holdings
1.0%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
24,224
Price
$2.14
Total Value
$51.84K
Shares Held After
764,629
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
1
Price
$18.00
Total Value
$18.00
Shares Held After
358,233
% of Holdings
0.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
556
Price
$2.52
Total Value
$1.40K
Shares Held After
186,730
% of Holdings
0.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
8,120
Price
$19.00
Total Value
$154.28K
Shares Held After
1,179,524
% of Holdings
0.7%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
3,686
Price
$19.69
Total Value
$72.58K
Shares Held After
144,985
% of Holdings
2.5%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
1,843
Price
$19.69
Total Value
$36.29K
Shares Held After
148,671
% of Holdings
1.2%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
1,844
Price
$19.69
Total Value
$36.31K
Shares Held After
150,514
% of Holdings
1.2%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
12,528
Price
$45.27
Total Value
$567.14K
Shares Held After
12,546
% of Holdings
50.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Hodgson Ian — Chief Operating Officer
Shares
2,415
Price
$8.09
Total Value
$19.54K
Shares Held After
51,927
% of Holdings
4.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Smethurst Dominic — Chief Medical Officer
Shares
3,285
Price
$8.09
Total Value
$26.57K
Shares Held After
95,887
% of Holdings
3.3%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Schafer Joshua — CCO
Shares
10,500
Price
$9.19
Total Value
$96.50K
Shares Held After
62,278
% of Holdings
14.4%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Shares
3,000
Price
$9.18
Total Value
$27.55K
Shares Held After
29,590
% of Holdings
9.2%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
6,195
Price
$42.84
Total Value
$265.41K
Shares Held After
23,972
% of Holdings
20.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
108,759
Price
$42.84
Total Value
$4.66M
Shares Held After
183,656
% of Holdings
37.2%
Karyopharm Therapeutics Inc. (KPTI)
Macomber Lori — EVP, CFO & Treasurer
Shares
1,626
Price
$6.30
Total Value
$10.24K
Shares Held After
85,105
% of Holdings
1.9%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
795
Price
$155.77
Total Value
$123.84K
Shares Held After
84,112
% of Holdings
0.9%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
640
Price
$156.27
Total Value
$100.01K
Shares Held After
56,397
% of Holdings
1.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,009
Price
$156.34
Total Value
$470.43K
Shares Held After
303,882
% of Holdings
1.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
748
Price
$156.34
Total Value
$116.94K
Shares Held After
79,758
% of Holdings
0.9%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
791
Price
$156.17
Total Value
$123.53K
Shares Held After
106,810
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
7,175
Price
$32.12
Total Value
$230.46K
Shares Held After
108,205
% of Holdings
6.2%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
12,446
Price
$32.87
Total Value
$409.10K
Shares Held After
109,087
% of Holdings
10.2%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
4,333
Price
$32.12
Total Value
$139.18K
Shares Held After
49,080
% of Holdings
8.1%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — CHIEF COMMERCIAL OFFICER
Shares
7,310
Price
$32.12
Total Value
$234.80K
Shares Held After
131,823
% of Holdings
5.3%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
7,242
Price
$32.12
Total Value
$232.61K
Shares Held After
112,971
% of Holdings
6.0%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
33,635
Price
$32.70
Total Value
$1.10M
Shares Held After
432,886
% of Holdings
7.2%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
66,452
Price
$32.06
Total Value
$2.13M
Shares Held After
466,521
% of Holdings
12.5%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
6,956
Price
$32.12
Total Value
$223.43K
Shares Held After
107,485
% of Holdings
6.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,177
Price
$21.94
Total Value
$47.76K
Shares Held After
641,682
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,178
Price
$21.94
Total Value
$47.79K
Shares Held After
641,685
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$474.23
Total Value
$23.71K
Shares Held After
270
% of Holdings
15.6%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
18,891
Price
$2.20
Total Value
$41.56K
Shares Held After
788,853
% of Holdings
2.3%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
18,442
Price
$2.20
Total Value
$40.57K
Shares Held After
1,100,008
% of Holdings
1.6%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
7,039
Price
$18.02
Total Value
$126.84K
Shares Held After
358,234
% of Holdings
1.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
14,043
Price
$32.87
Total Value
$461.59K
Shares Held After
657,540
% of Holdings
2.1%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
957
Price
$31.82
Total Value
$30.45K
Shares Held After
671,583
% of Holdings
0.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
2,540
Price
$2.55
Total Value
$6.48K
Shares Held After
187,286
% of Holdings
1.3%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
5,455
Price
$9.14
Total Value
$49.86K
Shares Held After
383,837
% of Holdings
1.4%
Showing 2451–2500 of 3324 transactions (page 50 of 67)